Doximity, Inc.DOCSNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+25.2%
5Y CAGR-1.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+25.2%/yr
Quarterly compound
5Y CAGR
-1.4%/yr
Recent acceleration
Percentile
P92
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 14.55% |
| Q3 2025 | 12.70% |
| Q2 2025 | 8.05% |
| Q1 2025 | 10.62% |
| Q4 2024 | -3.52% |
| Q3 2024 | 2.95% |
| Q2 2024 | 12.04% |
| Q1 2024 | 1.01% |
| Q4 2023 | -0.06% |
| Q3 2023 | -9.00% |
| Q2 2023 | 1.81% |
| Q1 2023 | 4.98% |
| Q4 2022 | 7.41% |
| Q3 2022 | 0.43% |
| Q2 2022 | 9.17% |
| Q1 2022 | 7.39% |
| Q4 2021 | 4.95% |
| Q3 2021 | 16.76% |
| Q2 2021 | 5.44% |
| Q1 2021 | 10.10% |
| Q4 2020 | 15.61% |
| Q3 2020 | -1.76% |
| Q2 2020 | 12.96% |
| Q1 2020 | 3.32% |
| Q4 2019 | 0.00% |